62 results on '"Kuwagata M"'
Search Results
2. EFFECT OF SODIUM (META) ARSENITE ON RAT FETAL BRAIN.: P-69
- Author
-
Kuwagata, M, Senuma, M, Ogawa, T, and Shioda, S
- Published
- 2012
3. Valproate-induced developmental neurotoxicity in animals: DNT-3
- Author
-
Ogawa, T, Kuwagata, M, and Shioda, S
- Published
- 2012
4. Current problems of in vivo study and new in vivo approach focusing on each step of the developing CNS: DNT-2
- Author
-
Kuwagata, M
- Published
- 2011
- Full Text
- View/download PDF
5. Fetal brain observations in developmental neurotoxicity studies: Effects of prenatal valproic acid exposure on early development of the central nervous system: O-51
- Author
-
Kuwagata, M., Ogawa, T., Shioda, S., and Nagata, T.
- Published
- 2008
6. For developmental neurotoxicity studies, it may be better to start with mating the animals at your laboratory?: O-50
- Author
-
Ogawa, T., Kuwagata, M., and Shioda, S.
- Published
- 2008
7. Teratogenicity and maternal effects of Lactobacillus brevis KB290 in rats and rabbits
- Author
-
Yakabe, T., primary, Takashima, H., additional, Kuwagata, M., additional, Fukao, M., additional, Kikuchi, S., additional, and Yajima, N., additional
- Published
- 2011
- Full Text
- View/download PDF
8. Valproate-induced developmental neurotoxicity is affected by maternal conditions including shipping stress and environmental change during early pregnancy
- Author
-
OGAWA, T, primary, KUWAGATA, M, additional, HORI, Y, additional, and SHIODA, S, additional
- Published
- 2007
- Full Text
- View/download PDF
9. P12-16 Detection of extracellular vesicles (EVs) in hepatotoxicity using CD9-EGFP reporter mouse.
- Author
-
Ono, R., Naruse, M., Kuwagata, M., Yoshioka, Y., Hirabayashi, Y., Ochiya, T., Ikawa, M., and Kitajima, S.
- Subjects
- *
EXTRACELLULAR vesicles , *HEPATOTOXICOLOGY , *MICE - Published
- 2024
- Full Text
- View/download PDF
10. Late preconditioning in rat retina: involvement of adenosine and ATP-sensitive K+ channel
- Author
-
Sakamoto, K., Kuwagata, M., Nakahara, T., and Ishii, K.
- Published
- 2001
- Full Text
- View/download PDF
11. Current activities between the DevTox Berlin workshops and the Japanese Teratology Society Terminology Committee in harmonizing the terminology for classifying anomalies in laboratory animals in developmental toxicity studies: Report from the Satellite Workshop of the 60th Annual Meeting of the Japanese Teratology Society.
- Author
-
Kuwagata M, Sato A, Izumi Y, Chihara K, Yamasaki H, Katsumata Y, Ooshima Y, Buschmann J, and Fujiwara M
- Subjects
- Animals, Berlin, Fetus abnormalities, Fetus drug effects, Japan, Abnormalities, Drug-Induced, Animals, Laboratory abnormalities, Teratology
- Abstract
In recent years, the Japanese Teratology Society has worked with the DevTox Berlin Workshops project to provide internationally consistent terminology for teratogenic effects. This paper summarizes a satellite workshop of the 60th Annual Meeting of the Japanese Teratology Society, which was entitled "Current activities between DevTox Berlin Workshops to develop a harmonized terminology for classifying anomalies in laboratory animals in developmental toxicity studies." The Japanese Teratology Society - Laboratory Animal Terminology Project (JTS-LATP) reviewed "gray zone" anomalies and focused on developing criteria for reclassifying a large number of gray zone anomalies to clarify them and to make it easier to judge fetal categories. This effort will lead to international agreement, based on shared conceptions. The present article aimed to provide the reader with a summary of the issues discussed at the 2020 satellite meeting, which included discussions on open issues from the DevTox Berlin Workshops, ongoing work by the JTS-LATP on gray zone (GZ) anomalies, current industrial concerns, and future challenges., (© 2022 Japanese Teratology Society.)
- Published
- 2022
- Full Text
- View/download PDF
12. 25th anniversary of the Berlin workshop on developmental toxicology: DevTox database update, challenges in risk assessment of developmental neurotoxicity and alternative methodologies in bone development and growth.
- Author
-
Marx-Stoelting P, Solano MLM, Aoyama H, Adams RH, Bal-Price A, Buschmann J, Chahoud I, Clark R, Fang T, Fujiwara M, Gelinsky M, Grote K, Horimoto M, Bennekou SH, Kellner R, Kuwagata M, Leist M, Lang A, Li W, Mantovani A, Makris SL, Paumgartten F, Perron M, Sachana M, Schmitt A, Schneider S, Schönfelder G, Schulze F, Shiota K, and Solecki R
- Subjects
- Anniversaries and Special Events, Berlin, Internet Use, Nervous System drug effects, Nervous System growth & development, Risk Assessment, Bone Development drug effects, Education, Nervous System Diseases chemically induced, Toxicology methods
- Abstract
25 years after the first Berlin Workshop on Developmental Toxicity this 10th Berlin Workshop aimed to bring together international experts from authorities, academia and industry to consider scientific, methodologic and regulatory aspects in risk assessment of developmental toxicity and to debate alternative strategies in testing developmental effects in the future. Proposals for improvement of the categorization of developmental effects were discussed as well as the update of the DevTox database as valuable tool for harmonization. The development of adverse outcome pathways relevant to developmental neurotoxicity (DNT) was debated as a fundamental improvement to guide the screening and testing for DNT using alternatives to animal methods. A further focus was the implementation of an in vitro mechanism-based battery, which can support various regulatory applications associated with the assessment of chemicals and mixtures. More interdisciplinary and translation research should be initiated to accelerate the development of new technologies to test developmental toxicity. Technologies in the pipeline are (i) high throughput imaging techniques, (ii) models for DNT screening tests, (iii) use of computer tomography for assessment of thoracolumbar supernumerary ribs in animal models, and (iv) 3D biofabrication of bone development and regeneration tissue models. In addition, increased collaboration with the medical community was suggested to improve the relevance of test results to humans and identify more clinically relevant endpoints. Finally, the participants agreed that this conference facilitated better understanding innovative approaches that can be useful for the identification of developmental health risks due to exposure to chemical substances., (Copyright © 2020. Published by Elsevier Inc.)
- Published
- 2021
- Full Text
- View/download PDF
13. Visualizing the spatial localization of ciclesonide and its metabolites in rat lungs after inhalation of 1-μm aerosol of ciclesonide by desorption electrospray ionization-time of flight mass spectrometry imaging.
- Author
-
Yamamoto E, Taquahashi Y, Kuwagata M, Saito H, Matsushita K, Toyoda T, Sato F, Kitajima S, Ogawa K, Izutsu KI, Saito Y, Hirabayashi Y, Iimura Y, Honma M, Okuda H, and Goda Y
- Subjects
- Administration, Inhalation, Aerosols chemistry, Animals, Epithelial Cells metabolism, Glucocorticoids blood, Pregnenediones blood, Pregnenediones metabolism, Pulmonary Alveoli metabolism, Rats, Rats, Sprague-Dawley, Tissue Distribution, COVID-19 Drug Treatment, Glucocorticoids administration & dosage, Glucocorticoids pharmacokinetics, Lung diagnostic imaging, Lung metabolism, Pregnenediones administration & dosage, Pregnenediones pharmacokinetics, Spectrometry, Mass, Electrospray Ionization methods
- Abstract
Inhaled ciclesonide (CIC), a corticosteroid used to treat asthma that is also being investigated for the treatment of corona virus disease 2019, hydrolyzes to desisobutyryl-ciclesonide (des-CIC) followed by reversible esterification when exposed to fatty acids in lungs. While previous studies have described the distribution and metabolism of the compounds after inhalation, spatial localization in the lungs remains unclear. We visualized two-dimensional spatial localization of CIC and its metabolites in rat lungs after administration of a single dose of a CIC aerosol (with the mass median aerodynamic diameter of 0.918-1.168 μm) using desorption electrospray ionization-time of flight mass spectrometry imaging (DESI-MSI). In the analysis, CIC, des-CIC, and des-CIC-oleate were imaged in frozen lung sections at high spatial and mass resolutions in negative-ion mode. MSI revealed the coexistence of CIC, des-CIC, and des-CIC-oleate on the airway epithelium, and the distribution of des-CIC and des-CIC-oleate in peripheral lung regions. In addition, a part of CIC independently localized on the airway epithelium. These results suggest that distribution of CIC and its metabolites in lungs is related to both the intended delivery of aerosols to pulmonary alveoli and peripheral regions, and the potential deposition of CIC particles on the airway epithelium., (Copyright © 2021 The Author(s). Published by Elsevier B.V. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
14. Pharmacokinetics of primary metabolites 5-hydroxythalidomide and 5'-hydroxythalidomide formed after oral administration of thalidomide in the rabbit, a thalidomide-sensitive species.
- Author
-
Kuwagata M, Hasegawa T, Takashima H, Shimizu M, Kitajima S, and Yamazaki H
- Subjects
- Administration, Oral, Animals, Male, Mice, Rabbits, Liver, Thalidomide analogs & derivatives, Thalidomide toxicity
- Abstract
The teratogenicity of the chemotherapeutic drug thalidomide is species-specific and affects humans, non-human primates, and rabbits. The primary oxidation of thalidomide in previously investigated rodents predominantly resulted in the formation of deactivated 5'-hydroxythalidomide. In the current study, similar in vivo biotransformations to 5-hydroxythalidomide and 5'-hydroxythalidomide were confirmed by the analysis of blood plasma from male rabbits, a thalidomide-sensitive species, after oral administration of thalidomide (2.0 mg/kg). Similar levels of thalidomide in seminal plasma and in blood plasma were detected using liquid chromatography-tandem mass spectrometry at 4 hr and 7 hr after oral doses in male rabbits. Seminal plasma concentrations of 5-hydroxythalidomide and 5'-hydroxythalidomide were also seen in male rabbits in a roughly similar time-dependent manner to those in the blood plasma after oral doses of thalidomide (2.0 mg/kg). Furthermore, the values generated by a simplified physiologically based pharmacokinetic rabbit model were in agreement with the measured in vivo blood plasma data under metabolic ratios of 0.01 for the hepatic intrinsic clearance of thalidomide to both unconjugated 5-hydroxythalidomide and 5'-hydroxythalidomide. These results suggest that metabolic activation of thalidomide may be dependent on rabbit liver enzymes just it was for cytochrome P450 enzymes in humanized-liver mice; in contrast, rodent livers predominantly mediate biotransformation of thalidomide to 5'-hydroxythalidomide. A developmental toxicity test system with experimental animals that involves intravaginal exposures to the chemotherapeutic drug thalidomide via semen should be considered in the future.
- Published
- 2021
- Full Text
- View/download PDF
15. Constructing a developmental and reproductive toxicity database of chemicals (DART NIHS DB) for integrated approaches to testing and assessment.
- Author
-
Yamada T, Miura M, Kawamura T, Ushida K, Inoue K, Kuwagata M, Katsutani N, and Hirose A
- Subjects
- Databases, Factual, Female, Humans, Pregnancy, Reproduction, Risk Assessment, Drug-Related Side Effects and Adverse Reactions, Toxicity Tests
- Abstract
Developmental and reproductive toxicity (DART) is an important endpoint, and databases (DBs) are essential for evaluating the risk of untested substances using alternative methods. We have constructed a reliable and transparent DART DB, which we named DART NIHS DB, using the publicly available datasets of DART studies of industrial chemicals conducted by Japanese government ministries in accordance with the corresponding OECD test guidelines (OECD TG421 and TG422). This DB is unique because its dataset chemicals have little overlap with those of ToxRefDB, which compiles large-scale DART data, and it is reliable because the included datasets were created after reviewing the individual study reports. In DART NIHS DB, 171 of 404 substances exhibited signs of DART, which occurred during fertility and early embryonic development (49 substances), organogenesis (59 substances), and the perinatal period (161 substances). When the lowest-observed-adverse-effect level (LOAEL) of DART was compared with that of repeated-dose toxicity (RDT), 15 substances (12%) had a lower LOAEL for DART than for RDT. Of these, five substances displayed significant DART at doses of ≤ 50 mg/kg bw/day. The chemical and toxicity information in this DB will be useful for the development of stage-specific adverse outcome pathways (AOPs) via integration with mechanistic information. The whole datasets of the DB can be implemented in read-across support tools such as the OECD QSAR Toolbox, which will further lead to future integrated approaches to testing and assessment based on AOPs.
- Published
- 2021
- Full Text
- View/download PDF
16. Novel hepatotoxicity biomarkers of extracellular vesicle (EV)-associated miRNAs induced by CCl4.
- Author
-
Ono R, Yoshioka Y, Furukawa Y, Naruse M, Kuwagata M, Ochiya T, Kitajima S, and Hirabayashi Y
- Abstract
Recent findings have revealed that extracellular vesicles (EVs) are secreted from cells and circulate in the blood. EVs are classified as exosomes (40-100 nm), microvesicles (50-1,000 nm) or apoptotic bodies (500-2,000 nm). EVs contain mRNAs, microRNAs, and DNAs and have the ability to transfer them from cell to cell. Recently, especially in humans, the diagnostic accuracy of tumor cell type-specific EV-associated miRNAs as biomarkers has been found to be more than 90 %. In addition, microRNAs contained in EVs in blood are being identified as specific biomarkers of chemical-induced inflammation and organ damage. Therefore, microRNAs contained in the EVs released into the blood from tissues and organs in response to adverse events such as exposure to chemical substances and drugs are expected to be useful as novel biomarkers for toxicity assessment. In this study, C57BL/6 J male mice orally dosed with carbon tetrachloride (CCl4) were used as a hepatotoxicity animal model. Here, we report that not only the known hepatotoxicity biomarkers miR-122 and miR-192 but also 42 novel EV-associated biomarkers were upregulated in mice dosed with CCl4. Some of these novel biomarkers may be expected to be able to use for better understanding the mechanism of toxicity. These results suggest that our newly developed protocol using EV-associated miRNAs as a biomarker would accelerate the rapid evaluation of toxicity caused by chemical substances and/or drugs., Competing Interests: The authors declare no competing interests., (© 2020 The Authors.)
- Published
- 2020
- Full Text
- View/download PDF
17. Hypothalamic Monoaminergic Pathology in a Neurodevelopmental Rat Model Showing Prenatal 5-Bromo-2'-Deoxyuridine Treatment-Induced Hyperactivity and Hyporeproductivity.
- Author
-
Kuwagata M, Muneoka K, Honda K, and Miyazaki A
- Subjects
- Animals, Antimetabolites pharmacology, Bromodeoxyuridine pharmacology, Disease Models, Animal, Female, Male, Neurodevelopmental Disorders chemically induced, Pregnancy, Prenatal Exposure Delayed Effects chemically induced, Prenatal Exposure Delayed Effects metabolism, Rats, Rats, Sprague-Dawley, Corpus Striatum metabolism, Dopamine metabolism, Hypothalamus metabolism, Neurodevelopmental Disorders metabolism, Serotonin metabolism, Sex Characteristics
- Abstract
Objective: Prenatal treatment of rats with 5-bromo-2'-deoxyuridine (BrdU) is a neurodevelopmental model showing hyperactivity and impaired sexual activity. Human neurodevelopmental disorders, such as autism, exhibit sex-related pathology, but sex-related neurodevelopment has not been fully investigated in this model. We conducted this study to facilitate the understanding of the pathophysiology of neurodevelopmental disorders., Methods: Pregnant rats received 50 mg/kg BrdU on gestational days 9-15. The tissue content of dopamine (DA), serotonin (5-HT), and their metabolites dihydroxyphenylacetic acid, homovanillic acid, and 5-hydroxyindoleacetic acid were measured in male and female offspring at 3 weeks (juveniles) and 10 weeks (adults) of age., Results: Prenatally BrdU-treated rats had reduced DA metabolism or DA content in the hypothalamus from the juvenile through the adult period without sex differences, but sex-specific striatal DA abnormalities emerged after maturation. A reduction in 5-HT metabolism was measured in the hypothalamus without sex differences throughout development. Developmental alterations in the striatal 5-HT states were sex-dependent. Temporal changes in DA or 5-HT metabolism were found in the frontal cortex and midbrain., Conclusion: The sex-specific influence of a genotoxic factor on the development of the DA and 5-HT systems was clarified in the hypothalamus and striatum. The results suggest that the observed sex dependence and region specificity are related to the pathology of social dysfunction in neurodevelopmental disorders., (© 2019 S. Karger AG, Basel.)
- Published
- 2020
- Full Text
- View/download PDF
18. Induction of a thoracolumbar supernumerary rib in rat developmental toxicity studies: A short discussion on the critical window.
- Author
-
Kuwagata M, Senuma M, Todoroki M, Kumagai F, Kumamoto T, and Ogawa T
- Subjects
- Animals, Fetus drug effects, Flucytosine toxicity, Humans, Musculoskeletal Abnormalities chemically induced, Rats, Ribs growth & development, Sodium Salicylate toxicity, Teratogens pharmacology, Teratogens toxicity, Abnormalities, Drug-Induced physiopathology, Fetus physiopathology, Musculoskeletal Abnormalities physiopathology, Ribs physiopathology
- Abstract
Thoracolumbar supernumerary ribs (TSRs) are classified as less severe skeletal anomalies in rat developmental toxicity studies, although their incidence is relatively high in rodent studies. To investigate the characteristics of the critical window for chemically-induced TSR, in this study, rats were administered 5-fluorocytocine (5-FC) or sodium salicylate (SAL) at one of three time periods on gestational day (GD) 9, early morning (7:00 am), midday (12:00 pm to 1:00 pm), or late afternoon (4:00 pm or 7:00 pm). The incidence of TSR and other anomalies were assessed in GD20 fetuses. A single treatment with both chemicals on GD9-induced TSR, with the incidence highest when administered at 7:00 Am, decreasing gradually when administered later. This trajectory was clearer in rats treated with 5-FC than with SAL. The critical period of TSR induction is shorter in rats administered 5-FC than SAL. The characteristics of the critical window may cause variability in the incidence of TSR observed in developmental toxicity studies., (© 2018 Japanese Teratology Society.)
- Published
- 2019
- Full Text
- View/download PDF
19. Update of the DevTox data database for harmonized risk assessment and alternative methodologies in developmental toxicology: Report of the 9th Berlin Workshop on Developmental Toxicity.
- Author
-
Solecki R, Rauch M, Gall A, Buschmann J, Kellner R, Kucheryavenko O, Schmitt A, Delrue N, Li W, Hu J, Fujiwara M, Kuwagata M, Mantovani A, Makris SL, Paumgartten F, Schönfelder G, Schneider S, Vogl S, Kleinstreuer N, Schneider M, Schulze F, Fritsche E, Clark R, Shiota K, and Chahoud I
- Subjects
- Animal Use Alternatives trends, Animals, Berlin, Risk Assessment, Species Specificity, Terminology as Topic, Toxicology trends, Animal Use Alternatives methods, Databases, Factual trends, Reproduction drug effects, Toxicology methods
- Abstract
Representatives of applied science (e.g. governmental organizations, academia, and industry) met to discuss the progress towards a harmonized human health risk assessment in developmental toxicology of plant protection products, biocidal products, and other environmental chemicals at the 9
th Berlin Workshop on Developmental Toxicity held in September 2018. Within the focus of the scientific discussion were the future of in-vitro methods for developmental and reproductive toxicology, the potential relevance of alternative species in testing of developmental effects, and risk and hazard assessment of developmental and endocrine effects. Furthermore, the need for a harmonized terminology for classification of anomalies in laboratory animals in developmental toxicity studies aiming for human health risk assessment was determined. Here, the DevTox database was identified as an extremely valuable tool. Overall, the participants agreed that still one of the biggest challenges for testing developmental toxicity in the 21st century is the development of animal-free test strategies and alternatives to animal testing that could provide human-relevant information in a rapid, efficient, and mechanistically informative manner., (Copyright © 2019.)- Published
- 2019
- Full Text
- View/download PDF
20. Historical control data on developmental toxicity studies in rats.
- Author
-
Kuwagata M, Sakai Y, Tanaka S, Takashima H, Katagiri R, Matsuoka T, Noritake K, Senuma M, Shimizu T, Hojo H, Ibi K, Kudo S, Oota T, Ube M, Miwa Y, Kajita S, Uesugi T, Yabe K, Tateishi T, Nakano N, Taniguchi T, Yamashita A, Hirano T, Kirihata Y, Sakai Y, Nishizawa S, Fujiwara M, Mineshima H, Horimoto M, and Ema M
- Subjects
- Animals, Disease Models, Animal, Female, Immunohistochemistry, Male, Phenotype, Pregnancy, Rats, Rats, Sprague-Dawley, Rats, Wistar, Reproducibility of Results, Developmental Disabilities etiology, Developmental Disabilities pathology
- Abstract
Historical control data from prenatal developmental toxicity studies in rats have been used to evaluate whether toxicology outcomes were induced by exposure to a chemical or were within the range of spontaneous variation. These data are also important for monitoring animal characteristics. As a follow-up to historical control data from 1998 to 2010, this study analyzed control data from prenatal developmental studies performed in rats from 2011 to 2015. Data were collected from studies performed by 24 Japanese laboratories, including 15 pharmaceutical and chemical companies and nine contract research organizations, in Sprague-Dawley and two-sub-strains of Wistar Hannover rats. The data included maternal reproductive findings at terminal cesarean section and fetal findings, including incidences of spontaneous external, visceral, and skeletal anomalies. No noticeable differences in maternal reproductive data were observed among laboratories. The inter-laboratory variations in the incidences of fetal anomalies seemed to be due to differences in the selection of observation parameters, observation criteria, and classification of the findings, as well as to differences in terminology of fetal alterations. These historical control data may be helpful for adequate interpretation of experimental results and for evaluating the reproductive and developmental toxicities of various chemicals., (© 2018 Japanese Teratology Society.)
- Published
- 2019
- Full Text
- View/download PDF
21. Stress-reactive rats (high-avoidance female rats) have a shorter lifespan than stress-nonreactive rats (low-avoidance female rats).
- Author
-
Ohta R, Kumagai F, Marumo H, Usumi K, Saito Y, and Kuwagata M
- Abstract
Although Hatano high-avoidance and low-avoidance rats (HAA and LAA, respectively) have been selectively bred for good versus poor avoidance learning, HAA rats are known to be more reactive to stress than LAA rats. In this study, HAA and LAA female rats were compared during reproductive aging by observing estrous cycles from 8 to 11 months of age. Furthermore, these rats were allowed to live out their natural lifespans, that is, until 24 months of age, in order to compare their survival and to clarify the relationship between reproductive aging and tumor development. At eight months of age, 2 of 35 HAA rats and 20 of 35 LAA rats had abnormal estrous cycles. The median lifespan of the HAA rats (673 days) was shorter than that of the LAA rats (733 days). The incidence of pituitary neoplasia was higher in the HAA rats than in the LAA rats. These results suggest that HAA female rats (i.e., stress-reactive rats) have a shorter lifespan than LAA female rats (i.e., stress-nonreactive rats) and develop pituitary neoplasia, which was one of the causal factors in their accelerated mortality. However, the onset of an age-matched abnormal cycle did not correspond with their lifespan.
- Published
- 2016
- Full Text
- View/download PDF
22. Distinct effects of the serotonin-noradrenaline reuptake inhibitors milnacipran and venlafaxine on rat pineal monoamines.
- Author
-
Muneoka K, Kuwagata M, Ogawa T, and Shioda S
- Subjects
- Animals, Antidepressive Agents pharmacology, Male, Milnacipran, Norepinephrine analysis, Rats, Rats, Sprague-Dawley, Serotonin analysis, Adrenergic Uptake Inhibitors pharmacology, Biogenic Monoamines analysis, Cyclopropanes pharmacology, Pineal Gland chemistry, Pineal Gland drug effects, Selective Serotonin Reuptake Inhibitors pharmacology, Venlafaxine Hydrochloride pharmacology
- Abstract
Monoamine systems are involved in the pathology and therapeutic mechanism of depression. The pineal gland contains large amounts of serotonin as a precursor for melatonin, and its activity is controlled by noradrenergic sympathetic nerves. Pineal diurnal activity and its release of melatonin are relevant to aberrant states observed in depression. We investigated the effects on pineal monoamines of serotonin-noradrenaline reuptake inhibitors, which are widely used antidepressants. Four days of milnacipran treatment led to an increase in noradrenaline and serotonin levels, whereas 4 days of venlafaxine treatment reduced 5-hydroxyindoleacetic acid levels; both agents induced an increase in dopamine levels. Our data suggest that milnacipran increases levels of the precursor for melatonin synthesis by facilitating the noradrenergic regulation of pineal activity and that venlafaxine inhibits serotonin reuptake into noradrenergic terminals on the pineal gland.
- Published
- 2015
- Full Text
- View/download PDF
23. Mother/offspring co-administration of the traditional herbal remedy yokukansan during the nursing period influences grooming and cerebellar serotonin levels in a rat model of neurodevelopmental disorders.
- Author
-
Muneoka K, Kuwagata M, Ogawa T, and Shioda S
- Subjects
- Animals, Animals, Newborn, Autism Spectrum Disorder, Bromodeoxyuridine, Cerebellum growth & development, Cerebellum metabolism, Defecation drug effects, Disease Models, Animal, Dopamine metabolism, Exploratory Behavior drug effects, Female, Lactation, Male, Mothers, Motor Activity drug effects, Psychomotor Agitation metabolism, Random Allocation, Rats, Sprague-Dawley, Urination drug effects, Cerebellum drug effects, Drugs, Chinese Herbal administration & dosage, Grooming drug effects, Hypnotics and Sedatives administration & dosage, Psychomotor Agitation drug therapy, Serotonin metabolism, Serotonin Receptor Agonists administration & dosage
- Abstract
Neurodevelopmental impairment in the serotonergic system may be involved in autism spectrum disorder. Yokukansan is a traditional herbal remedy for restlessness and agitation in children, and mother-infant co-administration (MICA) to both the child and the nursing mother is one of the recommended treatment approaches. Recent studies have revealed the neuropharmacological properties of Yokukansan (YKS), including its 5-HT1A (serotonin) receptor agonistic effects. We investigated the influence of YKS treatment on behavior in a novel environment and on brain monoamine metabolism during the nursing period in an animal model of neurodevelopmental disorders, prenatally BrdU (5-bromo-2'-deoxyuridine)-treated rats (BrdU-rats). YKS treatment did not influence locomotor activity in BrdU-rats but reduced grooming in open-field tests. YKS treatment without MICA disrupted the correlation between locomotor behaviors and rearing and altered levels of serotonin and its metabolite in the cerebellum. These effects were not observed in the group receiving YKS treatment with MICA. These data indicate a direct pharmacological effect of YKS on the development of grooming behavior and profound effects on cerebellar serotonin metabolism, which is thought to be influenced by nursing conditions.
- Published
- 2015
- Full Text
- View/download PDF
24. Prenatal sodium arsenite affects early development of serotonergic neurons in the fetal rat brain.
- Author
-
Senuma M, Mori C, Ogawa T, and Kuwagata M
- Subjects
- Age Factors, Animals, Animals, Newborn, Body Weight drug effects, Brain embryology, Cell Proliferation drug effects, Dose-Response Relationship, Drug, Embryo, Mammalian, Female, Male, Pregnancy, Rats, Rats, Sprague-Dawley, Serotonin metabolism, Tyrosine 3-Monooxygenase metabolism, Arsenates toxicity, Brain pathology, Developmental Disabilities etiology, Prenatal Exposure Delayed Effects pathology, Prenatal Exposure Delayed Effects physiopathology, Serotonergic Neurons pathology
- Abstract
Prenatal arsenite exposure has been associated with developmental disorders in children, including reduced IQ and language abnormalities. Animal experiments have also shown that exposure to arsenite during development induced developmental neurotoxicity after birth. However, the evidence is not enough, and the mechanism is poorly understood, especially on the exposure during early brain development. This study assessed effects of sodium (meta) arsenite shortly after exposure on early developing fetal rat brains. Pregnant rats were administered 50 mg/L arsenite in their drinking water or 20 mg/kg arsenite orally using a gastric tube, on gestational days (GD) 9-15. Fetal brains were examined on GD16. Pregnant rats administered 20 mg/kg arsenite showed reductions in maternal body weight gain and food consumption during treatment, but not with 50 mg/L arsenite. Arsenite did not affect fetal development, as determined by body weight, mortality and brain size. Arsenite also did not induce excessive cell death or affect neural cell division in any region of the fetal neuroepithelium. Thyrosine hydroxylase immunohistochemistry revealed no difference in the distribution of catecholaminergic neurons between fetuses of arsenite treated and control rats. However, reductions in the number of serotonin positive cells in the fetal median and dorsal raphe nuclei were observed following maternal treatment with 20mg/kg arsenite. Image analysis showed that the serotonin positive areas decreased in all fetal mid- and hind-brain areas without altering distribution patterns. Maternal stress induced by arsenite toxicity did not alter fetal development. These results suggest that arsenite-induced neurodevelopmental toxicity involves defects in the early development of the serotonin nervous system., (Copyright © 2014 ISDN. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
25. Seeking genes responsible for developmental origins of health and disease from the fetal mouse liver following maternal food restriction.
- Author
-
Ogawa T, Shibato J, Rakwal R, Saito T, Tamura G, Kuwagata M, and Shioda S
- Subjects
- Adult, Animals, Caloric Restriction, DNA Methylation genetics, Female, Fetus, Gene Expression Profiling, Gene Expression Regulation, Developmental genetics, Humans, Liver metabolism, Liver pathology, Mice, Molecular Sequence Data, Pregnancy, Promoter Regions, Genetic, Protein Serine-Threonine Kinases biosynthesis, Intracellular Signaling Peptides and Proteins biosynthesis, Maternal-Fetal Exchange genetics, Prenatal Exposure Delayed Effects, Protein Serine-Threonine Kinases antagonists & inhibitors, Receptors, Leptin biosynthesis
- Abstract
Low birthweight resulting from a non-optimal fetal environment is correlated epidemiologically to a higher risk of adult diseases, and which has also been demonstrated using animal models for maternal undernutrition. In this study, we subjected pregnant mice to 50% food restriction (FR), and profiled gene expression and promoter DNA methylation genome-wide using the fetal livers. The fact that effect of food restriction is opposite between before and after birth encouraged us to hunt for genes that are expressed oppositely to adult calorie restriction (CR) using the maternal livers. Among oppositely regulated genes, we identified trib1 (tribbles homolog 1). Using genetically modified mice, trib1 has been shown to have a demonstrable contribution to a risk of hypertriglyceridaemia and insulin resistance. Our data showed that the trib1 expression and its promoter DNA methylation could be affected physiologically (by maternal nutrition), and therefore might be a strong candidate gene for developmental origins of adult diseases. Furthermore, lepr (leptin receptor) gene was downregulated by maternal FR, indicating its potential role in induction of obesity and diabetes. Gene expression as well as promoter DNA methylation profiling revealed that glucocorticoid receptor target genes were regulated by maternal FR. This supports previous studies that suggest an important role of fetal glucocorticoid exposure in the mechanism of developmental origins of diseases. Our transcriptomics profiling data also suggested that maternal FR impaired development of the immune system. An inventory of candidate genes responsible for developmental origins of health and disease is presented and discussed in this study., (© 2014 Japanese Teratology Society.)
- Published
- 2014
- Full Text
- View/download PDF
26. Tranexamic acid induces kaolin intake stimulating a pathway involving tachykinin neurokinin 1 receptors in rats.
- Author
-
Kakiuchi H, Kawarai-Shimamura A, Kuwagata M, and Orito K
- Subjects
- Animals, Antiemetics pharmacology, Aprepitant, Area Postrema cytology, Area Postrema drug effects, Area Postrema metabolism, Domperidone pharmacology, Dopamine Antagonists pharmacology, Male, Morpholines pharmacology, Neurokinin-1 Receptor Antagonists pharmacology, Ondansetron pharmacology, Proto-Oncogene Proteins c-fos metabolism, Rats, Rats, Wistar, Serotonin Antagonists pharmacology, Solitary Nucleus cytology, Solitary Nucleus drug effects, Solitary Nucleus metabolism, Antifibrinolytic Agents pharmacology, Kaolin administration & dosage, Receptors, Neurokinin-1 metabolism, Tranexamic Acid pharmacology
- Abstract
Tranexamic acid suppresses post-partum haemorrhage and idiopathic menorrhagia through its anti-fibrinolytic action. Although it is clinically useful, it is associated with high risks of side effects such as emesis. Understanding the mechanisms underlying tranexamic acid-induced emesis is very important to explore appropriate anti-emetic drugs for the prevention and/or suppression of emesis. In this study, we examined the receptors involved in tranexamic acid-induced kaolin intake in rats, which reflects the drug's clinical emetogenic potential in humans. Further, we examined the brain regions activated by administration of tranexamic acid and elucidated pivotal pathways of tranexamic acid-induced kaolin intake. We examined the effects of ondansetron, a 5-hydroxytryptamine 3 receptor antagonist, domperidone, a dopamine 2 receptor antagonist, and aprepitant, a tachykinin neurokinin 1 (NK1) receptor antagonist, on tranexamic acid-induced kaolin intake in rats. Then, we determined the brain regions that showed increased numbers of c-Fos immunoreactive cells. Finally, we examined the effects of an antagonist(s) that reduced tranexamic acid-induced kaolin intake on the increase in c-Fos immunoreactive cells. Aprepitant significantly decreased tranexamic acid-induced kaolin intake. However, neither ondansetron nor domperidone decreased kaolin intake. Tranexamic acid significantly increased c-Fos immunoreactive cells by approximately 5.5-fold and 22-fold in the area postrema and nucleus of solitary tract, respectively. Aprepitant decreased the number of c-Fos immunoreactive cells in both areas. Tranexamic acid induced kaolin intake possibly via stimulation of tachykinin NK1 receptors in rats. The tachykinin NK1 receptor could be targeted to prevent and/or suppress emesis in patients receiving tranexamic acid., (© 2013 Published by Elsevier B.V.)
- Published
- 2014
- Full Text
- View/download PDF
27. Study for collecting background data on Wistar Hannover [Crl:WI(Han)] rats in general toxicity studies--comparative data to Sprague Dawley rats.
- Author
-
Hayakawa K, Mimura Y, Tachibana S, Furuya M, Kodama T, Aoki T, Hosokawa S, Fukui M, Shibata S, Yoshida M, Masuyama T, Narita T, Kuwagata M, Hisada S, and Maki E
- Subjects
- Alanine Transaminase blood, Animals, Aspartate Aminotransferases blood, Blood Cell Count, Corneal Opacity epidemiology, Female, Lipids blood, Male, Organ Size, Ovary, Rats, Testis, Thymus Gland, Body Weight, Eating, Models, Animal, Rats, Sprague-Dawley, Rats, Wistar, Toxicity Tests, Toxicology methods
- Abstract
The purpose of the present study was to collect background data from repeated dose toxicity studies in Wistar Hannover [Crl:WI(Han)] (hereafter Wistar Han) rats with dosing periods of 4, 13 and 26 weeks from four safety research facilities of pharmaceutical companies and contract research organizations participating in the International Genetic Standardization (IGS) rat forum supported by Charles River Laboratories Japan, Inc. The data from Wistar Han rats were compared with those from Sprague Dawley Crl:CD(SD) rats. In addition, the effects of restricted feeding of SD rats were also investigated by one facility. As a result, body weights and food consumption in Wistar Han rats were lower than those of SD rats. White blood cell (WBC), neutrophil, lymphocyte, monocyte and eosinophil counts were almost half of those noted for SD rats and platelet counts were almost 20% less than those in SD rats. Minimal strain differences were noted in several biochemical parameters including aspartate aminotransferase (AST), alanine aminotransferase, total cholesterol, triglyceride and phospholipids, and in thymus, ovary and testis weights. Ophthalmologic or histopathologic examinations revealed a higher incidence of corneal opacities or corneal mineralization in Wistar Han rats. Restricted feeding of SD rats resulted in intermediate values for body weights and food consumption between the ad libitum fed SD and Wistar Han rats, and WBC and AST were lower than those in the ad libitum fed SD rats. Based on these results, some strain differences might be ascribable to reduced food consumption and associated body weight changes in Wistar Han rats.
- Published
- 2013
- Full Text
- View/download PDF
28. Abnormal brain function of the rat neonate in a prenatal 5-bromo-2'-deoxyuridine (BrdU)-induced developmental disorder model.
- Author
-
Ogawa T, Kuwagata M, Muneoka K, Wakai C, Senuma M, Kubo H, and Shioda S
- Subjects
- Animals, Animals, Newborn, Brain pathology, Bromodeoxyuridine toxicity, Developmental Disabilities etiology, Disease Models, Animal, Female, Gene Expression Regulation, Developmental drug effects, Gene Expression Regulation, Developmental physiology, Male, Pregnancy, Prenatal Exposure Delayed Effects chemically induced, Proto-Oncogene Proteins c-fos metabolism, Rats, Rats, Sprague-Dawley, Social Isolation, Antimetabolites toxicity, Brain abnormalities, Developmental Disabilities pathology, Prenatal Exposure Delayed Effects physiopathology
- Abstract
Neonatal brain function was investigated in a prenatal BrdU-induced developmental disorder model, which has been reported to exhibit behavioral abnormalities such as locomotor hyperactivity, impaired learning and memory, and lower anxiety in offspring. After 1h home cage deprivation we observed an increase in the number of c-Fos (neuronal activity marker) immunoreactive cells in several brain regions of the olfactory and stress-related areas in normal neonates at 11 days. Next, pregnant rats were exposed to 50mg/kg of BrdU from gestation days 9-15, and their offspring at 11 days were home-cage deprived. Compared to vehicle control, the number of c-Fos immunoreactive cells in BrdU group was found to be decreased in the piriform cortex and locus coeruleus, which are known to play an important role in neonatal learning and memory. We also analyzed Pearson product-moment correlation coefficient of the number of c-Fos immunoreactive cells, focusing on the piriform cortex and locus coeruleus versus numerous other brain areas (11 areas including amygdala). Numerous significant correlations were observed in the vehicle control group, however, correlations of the locus coeruleus disappeared in the BrdU group. By observing c-Fos immunoreactivity after home cage deprivation our study uncovers abnormal brain functions as early as postnatal day 11 in this disorder model. Based on these results, we propose a new histological approach for functional characterization of developmental disorder models., (Copyright © 2012 ISDN. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
29. Current problems of in vivo developmental neurotoxicity tests and a new in vivo approach focusing on each step of the developing central nervous system.
- Author
-
Kuwagata M
- Subjects
- Animals, Animals, Newborn, Cell Differentiation, Cells, Cultured, Central Nervous System embryology, Central Nervous System growth & development, Humans, Models, Animal, Nerve Net, Nervous System Diseases pathology, Neural Stem Cells cytology, Neural Stem Cells drug effects, Neural Stem Cells metabolism, Central Nervous System drug effects, Nervous System Diseases chemically induced, Neurotoxicity Syndromes pathology
- Abstract
Developmental neurotoxicity (DNT) tests usually focus on postnatal indicators, such as behavior and neuropathology, for the detection of chemically induced neurodevelopmental defects in the central nervous system (CNS). However, low reliability, especially low reproducibility, of behavioral results often causes concern among scientists and the scientific community in general. Guidance of neurohistopathological examination in the DNT guideline also has some shortcomings, especially relating to the methodological aspects. Ongoing international trends in DNT tests have shifted from the use of original in vivo animal (mammalian) studies to in vitro experiments using cell cultures and/or non-mammalian species, such as fish. In vitro systems might initially be useful to screen test chemicals for their DNT potential. Although in vitro systems are employed as alternative approaches for DNT studies, the use of in vivo studies based on animal models remains an important factor when data are to be extrapolated to the human case. In this review, a new in vivo approach that focuses on histopathological observation of each developmental step of the CNS, such as proliferation of neural stem cells, migration of immature neurons, and formation of neural networks, using fetal and neonatal brains after chemical exposure is introduced, and some queries and arguments for current DNT experimental guidelines are discussed., (© 2012 The Author. Congenital Anomalies © 2012 Japanese Teratology Society.)
- Published
- 2012
- Full Text
- View/download PDF
30. Usefulness of combined in vivo skin comet assay and in vivo skin micronucleus test.
- Author
-
Toyoizumi T, Ohta R, Kawakami K, Nakagawa Y, Tazura Y, Kuwagata M, Noguchi S, Sui H, and Yamakage K
- Subjects
- Animals, Comet Assay methods, Liver drug effects, Male, Mice, Mice, Nude, Micronucleus Tests methods, Carcinogens toxicity, Mutagens toxicity, Skin drug effects
- Abstract
We have already found that the in vivo skin comet assay is useful for the evaluation of primary DNA damage induced by genotoxic chemicals in epidermal skin cells. The aim of the present study was to evaluate the sensitivity and specificity of the combined in vivo skin comet assay and in vivo skin micronucleus (MN) test using the same animal to explore the usefulness of the new test method. The combined alkaline comet assay and MN test was carried out with three chemicals: 4-nitroquinoline-1-oxide (4NQO), N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) and benzo[a]pyrene (B[a]P). In the first experiment, we compared DNA- and chromosome-damaging effects of 3 [72, 24 and 3 hours (h) before sacrifice] and 4 applications (72, 48, 24 and 3h before sacrifice) of 4NQO, which induces dermal irritancy. The animals were euthanized and their skin was sampled for the combination test. As a result, the 4-application method was able to detect both DNA- and chromosome-damaging potential with a lower concentration; therefore, in the second experiment, MNNG and B[a]P were topically applied four times, respectively. The animals were euthanized, and then their skins were sampled for combination tests. In the alkaline comet assay, significant differences in the percent of DNA (%DNA) in the tail were observed in epidermal skin cells treated with MNNG and B[a]P. In the MN test, an increased frequency of MN cells (%MN) cells was observed by treatment with MNNG; however, there were no significant increases. In contrast, significant differences in %MN were observed by treatment with B[a]P. From these results, we conclude that the combined in vivo skin comet assay and in vivo MN test was useful because it can detect different genotoxicity with the same sampling time and reduce the number of animals used., (© 2012 Elsevier B.V. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
31. Use of the in vivo skin comet assay to evaluate the DNA-damaging potential of chemicals applied to the skin.
- Author
-
Toyoizumi T, Ohta R, Nakagawa Y, Tazura Y, Kuwagata M, Noguchi S, and Yamakage K
- Subjects
- Animals, DNA Damage, Male, Mice, Mice, Hairless, Sensitivity and Specificity, Comet Assay methods, Mutagens toxicity, Skin drug effects
- Abstract
The aim of the present study was to evaluate both sensitivity and specificity of an in vivo skin comet assay using chemically treated, hairless mouse dorsal skin as a model. N-methyl-N'-nitro-N-nitrosoguanidine (MNNG, 0.0125-0.2%), 4-nitroquinoline-1-oxide (4NQO, 0.01-0.25%), mitomycin C (MMC, 0.0125-0.05%), benzo[a]pyrene (B[a]P, 0.25-2%), and 7,12-dimethylbenz[a]anthracene (DMBA, 0.25-1%) were each applied once to the dorsal skin of hairless male mice; after 3h, epidermal skin cells were isolated, and the alkaline comet assay was performed. The assay was performed after 24h for only the B[a]P and DMBA. Furthermore, B[a]P and DMBA were evaluated by alkaline comet assay using liver cells after both 3 and 24h. The mean percent of DNA (%DNA) in tail in the 0.05-0.2% MNNG and 0.1-0.25% 4NQO treatment groups was markedly higher than in the control group at 3h post-application. Although the mean %DNA values in the tail in the B[a]P and DMBA groups were the same as the controls at 3h post-application, the 2% B[a]P and 1% DMBA groups showed significantly higher values versus controls 24h after application. No significant increases in the mean %DNA in the tail were observed in the MMC group. No clear increases in %DNA in the tail were observed in the B[a]P and DMBA groups at 3 or 24h after application in the liver. These results suggest that the in vivo skin comet assay is able to accurately identify DNA-damaging potential with a skin-specific response and is a useful method to detect the DNA-damaging potential of genotoxic chemicals on the skin., (Copyright © 2011 Elsevier B.V. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
32. Hyperactivity induced by prenatal BrdU exposure across several experimental conditions.
- Author
-
Kuwagata M, Ogawa T, Muneoka K, and Shioda S
- Subjects
- Animals, Female, Hyperkinesis embryology, Mice, Mice, Inbred ICR, Neurotoxicity Syndromes embryology, Pregnancy, Rats, Rats, Inbred F344, Rats, Sprague-Dawley, Sex Factors, Species Specificity, Bromodeoxyuridine toxicity, Disease Models, Animal, Hyperkinesis etiology, Neurotoxicity Syndromes etiology, Neurotoxins toxicity, Prenatal Exposure Delayed Effects etiology
- Abstract
Behavioral results are sometimes not reproducible even in the positive controls of developmental neurotoxicity (DNT) tests. Effects of several factors on the results should be considered. In the present paper, we examined the effects of strain-, gender-, and test-condition differences on BrdU-induced hyperactivity. The results showed that BrdU-induced hyperactivity was reproducible in two rat strains (SD and F344 rats), rodent species (rat and mouse), and both sexes. When the level of background sound in a test room was increased, the hyperactivity was persistent, resulting in no effect of background sound on BrdU-induced hyperactivity. Thus, we have demonstrated that the BrdU-animal model is a useful positive control via prenatal exposure to validate the entire DNT test process., (© 2011 The Authors. Congenital Anomalies © 2011 Japanese Teratology Society.)
- Published
- 2011
- Full Text
- View/download PDF
33. Seeking gene candidates responsible for developmental origins of health and disease.
- Author
-
Ogawa T, Rakwal R, Shibato J, Sawa C, Saito T, Murayama A, Kuwagata M, Kageyama H, Yagi M, Satoh K, and Shioda S
- Subjects
- Animals, Female, Food Deprivation, Gene Expression Regulation, Genetic Association Studies, Health, High-Throughput Screening Assays, Liver anatomy & histology, Liver physiology, Mice, Mice, Inbred C57BL, Oligonucleotide Array Sequence Analysis, Pregnancy, RNA, Messenger genetics, RNA, Messenger metabolism, Disease genetics, Fetal Nutrition Disorders genetics, Liver metabolism, Longevity genetics
- Abstract
Human epidemiological evidence has led scientists to theorize that undernutrition during gestation is an important early origin of adult diseases. Animal models have successfully demonstrated that maternal diet could contribute to some adult diseases. Undernutrition is perceived harmful in pregnant women, whereas calorie restriction is a strategy proven to extend healthy and maximum lifespan in adult. This diagrammatically opposite effect of nutritional condition might provide us with hints to search for genes underlying health conditions. Here, we have initiated a study examining the effect of undernutrition on maternal and fetal livers, utilizing high-throughput DNA microarray analysis for screening genome-wide changes in their transcriptomes. Briefly, pregnant mice were exposed to food deprivation (FD) on gestation day (GD) 17, and cesarean section was performed on GD18. Control mice were supplied with chow ad libitum until sacrifice. Total RNA extracted from mother and fetal livers for each control and treatment (FD) was analyzed with an Agilent mouse whole genome DNA chip. A total of 3058 and 3126 up- (>1.5-fold) and down- (<0.75-fold) regulated genes, and 1475 and 1225 up- (>1.5-fold) and down- (<0.75-fold) regulated genes showed differential expression at the mRNA level, in the maternal and fetal livers, respectively. Interestingly, 103 genes up-regulated in the mother were down-regulated in the fetus, whereas 108 down-regulated maternal genes were up-regulated in the fetus; these 211 genes are potential candidates related to longevity or health. The role of some of these genes, in context of the proposed mechanisms for developmental origins of health and disease is discussed., (© 2011 The Authors. Congenital Anomalies © 2011 Japanese Teratology Society.)
- Published
- 2011
- Full Text
- View/download PDF
34. Distribution of the longevity gene product, SIRT1, in developing mouse organs.
- Author
-
Ogawa T, Wakai C, Saito T, Murayama A, Mimura Y, Youfu S, Nakamachi T, Kuwagata M, Satoh K, and Shioda S
- Subjects
- Animals, Fetal Development genetics, Gene Expression Regulation, Developmental, Longevity genetics, Mice, Mice, Inbred C57BL, Mice, Inbred ICR, Organ Specificity genetics, Sirtuin 1 genetics, Organogenesis genetics, Sirtuin 1 metabolism
- Abstract
A longevity gene product, Sir2 (silent information regulator 2) is a NAD-dependent histone deacetylase involved in longevity in yeasts, worms and flies. The mammalian homolog of Sir2, SIRT1(sirtuin 1), has been shown to play important roles related to anti-aging effects (regulating apoptosis, stress tolerance, insulin resistance, and fat metabolism). Recently, SIRT1 expression has been demonstrated to occur at as early as embryonic day 10.5 in mice. SIRT1 during developing period may be involved in the mechanism of developmental origins of adult diseases, such as diabetes and cardiovascular disease. To investigate the contribution of SIRT1, it is important to reveal the distribution of this protein during development. In the present study, we demonstrated the distribution of immunoreactivity of SIRT1 in mouse organs during prenatal and neonatal development by staining a wide variety of serial sections. The SIRT1 immunoreactivity was strongly observed in the neuroepithelial layer, dorsal root ganglion, trigeminal ganglion, eyes, roots of whiskers, and internal organs, including the testis, liver, heart, kidney, and lung during the fetal period. Neurons which had finished migrating still showed relatively strong immunoreactivity. The immunoreactivity was completely absorbed by the blocking peptide in an absorption test. During the postnatal period, the immunoreactivities in most of these organs, except the heart and testis weakened, with the liver most dramatically affected. As SIRT1 expression was demonstrated in a wide variety of developing organs, further study to investigate prenatal factors which affect SIRT1 expression and its activity is important., (© 2011 The Authors. Congenital Anomalies © 2011 Japanese Teratology Society.)
- Published
- 2011
- Full Text
- View/download PDF
35. Effects of the genotoxic agent 5-bromo-2'-deoxyuridine with or without pre-pubertal gonadectomy on brain monoamines and their metabolites in female rats.
- Author
-
Kuwagata M, Muneoka K, Ogawa T, and Shioda S
- Subjects
- Animals, Animals, Newborn, Brain anatomy & histology, Bromodeoxyuridine metabolism, Cell Count methods, Female, Male, Ovariectomy, Pregnancy, Prenatal Exposure Delayed Effects chemically induced, Rats, Rats, Sprague-Dawley, Biogenic Monoamines metabolism, Brain drug effects, Brain metabolism, Bromodeoxycytidine pharmacology, Prenatal Exposure Delayed Effects physiopathology
- Abstract
A nucleotide analog 5-bromo-2'-deoxyuridine (BrdU) is a genotoxic compound. Previous studies have demonstrated that prenatal treatment of rodents with BrdU affects the development of cortical neurons, reduces dopamine levels, and elevates serotonin (5-HT) levels in the striatum in adult male offspring from BrdU-treated dams. Moreover, prenatal BrdU-treated rats show locomotor hyperactivity in both males and females. This study investigated sexual dimorphism in the effect of prenatal BrdU on monoamine metabolism. Sprague-Dawley rats were treated with BrdU on gestational days 9-15 (50mg/kg, i.p.) and monoamine metabolism was examined in female rats at 10 weeks of age. The influence of pre-pubertal gonadectomy on the effects of BrdU was also investigated. BrdU-treated females showed elevations of dopamine and 5-HT levels in the striatum; reductions in dopamine, dihydroxyphenylacetic acid, or homovanillic acid (HVA) in the hypothalamus or the midbrain; and elevated HVA and 5-HT in the hippocampus. Pre-pubertal gonadectomy had a suppressive effect on striatal dopamine levels in prenatal BrdU-treated females. The present data indicate sexual dimorphic effects of prenatal BrdU-treatment in striatal dopamine metabolism but not in serotonergic metabolism and suggest a contribution of the increasing gonadal hormones that accompany puberty to this sex difference., (Copyright © 2011 Elsevier Inc. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
36. Sex-specific effects of early neonatal progesterone treatment on dopamine and serotonin metabolism in rat striatum and frontal cortex.
- Author
-
Muneoka K, Kuwagata M, Ogawa T, and Shioda S
- Subjects
- Animals, Animals, Newborn, Corpus Striatum drug effects, Corpus Striatum metabolism, Female, Frontal Lobe drug effects, Frontal Lobe metabolism, Male, Orchiectomy, Rats, Rats, Sprague-Dawley, Sex Characteristics, Time Factors, Dopamine metabolism, Hydroxyindoleacetic Acid metabolism, Pregnenolone pharmacology, Serotonin metabolism
- Abstract
Aims: The early neonatal period is critical for the development of the rodent brain. Neurosteroid levels in the brain decline from the late gestation to the neonatal period. Previous studies indicate effects of neurosteroid treatment during the neonatal period on the development of the dopaminergic system. In this study, we investigated the sex-specific effects of neonatal treatment with the neurosteroid progesterone on monoamine metabolism. Separately, we examined the contribution of pre-pubertal castration on the effect of neonatal treatment of pregnenolone (a neurosteroid precursor)., Main Methods: Progesterone (Experiment 1) or pregnenolone (Experiment 2) treatments in Sprague-Dawley rats were performed from postnatal days 3 through 7. Castration in experiment 2 was performed in male rats at postnatal day 21. We measured the brain tissue contents of dopamine, serotonin (5-HT), and their metabolites in rats at age 10 weeks., Key Findings: Results showed that neonatal progesterone treatment altered striatal 5-hydroxy-3-indolacetic acid/5-HT ratios in males and females in opposite directions, in addition to dopaminergic effects. The treatment also influenced dopamine and 5-HT metabolism without sex-specificity in the frontal cortex. In addition, there was no significant difference in striatal monoamine metabolism between sham-operated, castrated and castrated pregnenolone-treated group., Significance: The present result indicates a sex-specific influence of progesterone during the early neonatal period on the development of the serotonergic system, depending on brain region in addition to of the dopaminergic system., (Copyright © 2010 Elsevier Inc. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF
37. Biphasic effects of neonatal allopregnanolone on striatal dopamine metabolism.
- Author
-
Muneoka K, Kuwagata M, Shirayama Y, Ogawa T, and Shioda S
- Subjects
- Animals, Animals, Newborn, Cell Differentiation drug effects, Cell Differentiation physiology, Corpus Striatum drug effects, Dose-Response Relationship, Drug, Drug Administration Schedule, Female, Homovanillic Acid metabolism, Male, Neurogenesis drug effects, Neurogenesis physiology, Neurons drug effects, Pregnanolone pharmacology, Rats, Rats, Sprague-Dawley, Corpus Striatum growth & development, Corpus Striatum metabolism, Dopamine metabolism, Neurons metabolism, Pregnanolone metabolism
- Abstract
Neurosteroids are known to modulate the development of the mesocorticolimbic system. We examined the effects of low (1 mg/kg) and high (10 mg/kg) doses of allopregnanolone on monoamine metabolism during the neonatal period (postnatal days 3-7) in rats. At 10 weeks of age, increases in homovanillic acid/dopamine (DA) ratios were found in the striatum in both allopregnanolone-treated groups compared with control rats. However, striatal DA levels decreased only in the low-allopregnanolone group and striatal homovanillic acid levels increased only in the high-allopregnanolone group. Allopregnanolone did not significantly affect cortical DA metabolism, or cortical or striatal serotonin metabolism. Data indicate that neonatal allopregnanolone treatment has a biphasic effect on striatal DA metabolism.
- Published
- 2009
- Full Text
- View/download PDF
38. Observation of fetal brain in a rat valproate-induced autism model: a developmental neurotoxicity study.
- Author
-
Kuwagata M, Ogawa T, Shioda S, and Nagata T
- Subjects
- Animals, Disease Models, Animal, Female, Humans, Male, Neurotoxicity Syndromes etiology, Neurotoxicity Syndromes physiopathology, Pregnancy, Prenatal Exposure Delayed Effects chemically induced, Rats, Rats, Sprague-Dawley, Anticonvulsants pharmacology, Autistic Disorder chemically induced, Autistic Disorder physiopathology, Brain anatomy & histology, Brain drug effects, Brain pathology, Fetus drug effects, Fetus physiology, Valproic Acid pharmacology
- Abstract
Prenatal exposure to chemicals is well known to induce developmental abnormalities in the central nervous system of children. Developmental neurotoxicity (DNT) tests are important to identify neurotoxic agents and prevent neurodevelopmental disorders. We have investigated DNT, focusing on the fetal brain shortly after chemical exposure. To demonstrate a usefulness of a study focusing on the fetal brain in DNT tests, we assessed the fetal brain in a rat valproate-induced autism model. Rats were treated with sodium valproate (VPA, 800 mg/kg) orally on gestational day (GD) 9 or 11 (VPA9 or VPA11), and the fetal brains were examined on GD16 using immunohistochemistry for serotonin (5-HT), tyrosine hydroxylase (TH), and TuJ1 (neuron specific class III beta-tubulin). Hypoplasia of the cortical plate was induced in both VPA9 and VPA11 groups. Abnormal migration of TH-positive and 5-HT neurons, possibly due to the appearance of an abnormally running nerve tract in the pons, was observed only in the VPA11 group. In addition, when we compared the incidence of these abnormalities between pregnant rats mated in our own animal facility (in-house group), and rats purchased pregnant (supplier group), the supplier group was much more sensitive, especially to the pons abnormality. Shipping stress may affect the reproducibility of VPA-induced DNT. The present results demonstrate that examination of the GD16 fetal brain was useful for detecting and characterizing abnormal development of the brain after VPA exposure. Further discussion was made with reference to the findings in children with autism.
- Published
- 2009
- Full Text
- View/download PDF
39. Histological protection by cilnidipine, a dual L/N-type Ca(2+) channel blocker, against neurotoxicity induced by ischemia-reperfusion in rat retina.
- Author
-
Sakamoto K, Kawakami T, Shimada M, Yamaguchi A, Kuwagata M, Saito M, Nakahara T, and Ishii K
- Subjects
- Amlodipine therapeutic use, Animals, Calcium Channels, L-Type physiology, Calcium Channels, N-Type physiology, Drug Evaluation, Preclinical, In Situ Nick-End Labeling methods, Injections, Injections, Intravenous, Male, N-Methylaspartate, Nitroso Compounds, Rats, Rats, Sprague-Dawley, Reperfusion Injury metabolism, Reperfusion Injury pathology, Retinal Degeneration chemically induced, Retinal Degeneration pathology, Retinal Degeneration prevention & control, Retinal Diseases metabolism, Retinal Diseases pathology, Vitreous Body, omega-Conotoxins therapeutic use, Calcium Channel Blockers therapeutic use, Dihydropyridines therapeutic use, Neuroprotective Agents therapeutic use, Reperfusion Injury prevention & control, Retinal Diseases prevention & control
- Abstract
Although a blockade or lack of N-type Ca(2+) channels has been reported to suppress neuronal injury induced by ischemia-reperfusion in several animal models, information is still limited regarding the neuroprotective effects of a dual L/N-type Ca(2+) channel blocker, cilnidipine. We histologically examined the effects of cilnidipine on neuronal injury induced by ischemia-reperfusion, intravitreous N-methyl-D-aspartate (NMDA) (200nmol/eye) and intravitreous NOC12 (400nmol/eye), an nitric oxide donor, in the rat retina, and compared its effects with those of omega-conotoxin MV IIA, an N-type Ca(2+) channel blocker and amlodipine, an L-type Ca(2+) channel blocker. Morphometric evaluation at 7 days after ischemia-reperfusion showed that treatment with cilnidipine (100microg/kg, i.v. or 0.5pmol/eye, intravitreous injection) prior to ischemia dramatically reduced the retinal damage. Treatment with omega-conotoxin MV IIA before ischemia (0.1pmol/eye, intravitreous injection) significantly reduced the retinal damage. However, amlodipine (30-100microg/kg, i.v. or 0.1-1pmol/eye, intravitreous injection) did not show any protective effects. Treatment with cilnidipine (100microg/kg, i.v.) reduced the retinal damage induced by intravitreous NMDA, but not NOC12. These results suggest that cilnidipine reduces Ca(2+) influx via N-type Ca(2+) channels after NMDA receptors activation and then protects neurons against ischemia-reperfusion injury in the rat retina in vivo. Cilnidipine may be useful as a therapeutic drug against retinal diseases which cause neuronal cell death, such as glaucoma and central retinal vessel occlusion.
- Published
- 2009
- Full Text
- View/download PDF
40. Characteristic behavioral anomalies in rats prenatally exposed to 5-bromo-2'-deoxyuridine.
- Author
-
Orito K, Morishima A, Ogawa T, Muneoka K, Kuwagata M, Takata J, Mishima K, and Fujiwara M
- Subjects
- Animals, Animals, Newborn, Antidepressive Agents, Tricyclic pharmacology, Antimetabolites toxicity, Anxiety Disorders chemically induced, Anxiety Disorders physiopathology, Behavior, Animal drug effects, Behavior, Animal physiology, Biogenic Monoamines metabolism, Brain physiopathology, Central Nervous System Stimulants pharmacology, Disease Models, Animal, Female, Male, Maze Learning drug effects, Mental Disorders congenital, Mental Disorders physiopathology, Motor Activity drug effects, Pregnancy, Prenatal Exposure Delayed Effects pathology, Prenatal Exposure Delayed Effects physiopathology, Rats, Rats, Sprague-Dawley, Selective Serotonin Reuptake Inhibitors pharmacology, Brain drug effects, Brain growth & development, Bromodeoxyuridine toxicity, Mental Disorders chemically induced
- Abstract
The aim of the present study was to characterize behavioral anomalies in rats prenatally exposed to 5-bromo-2'-deoxyuridine, a useful model of hyperactive disorder. Rats were treated with BrdU at 50mg/kg IP or carboxymethylcellulose, its vehicle, on gestational Days 9 through 15, and their offsprings were subjected to behavioral tests. Rats prenatally exposed to 5-bromo-2'-deoxyuridine showed higher locomotor activity levels when the lights were turned off, and these levels kept increasing throughout the dark cycle. In an elevated plus maze, the rats prenatally exposed to 5-bromo-2'-deoxyuridine exhibited decreased anxiety-related behavior, including higher open arm entries and a longer time spent per one open arm entry when compared with rats prenatally exposed to carboxymethylcellulose. Methylphenidate, a psychostimulant that suppresses hyperactivity in humans with attention-deficit hyperactivity disorder, increased locomotor activity in both rats, with a greater sensitivity in rats prenatally exposed to 5-bromo-2'-deoxyuridine. Desipramine, a specific noradrenaline uptake inhibitor, normalized the hyperactivity of rats prenatally exposed to 5-bromo-2'-deoxyuridine. Paroxetine, a selective serotonin reuptake inhibitor, also normalized the hyperactivity and the low anxiety-related behavior in the elevated plus maze. These results suggest that rats prenatally exposed to 5-bromo-2'-deoxyuridine are hyperactive and exhibit a lower anxiety level. Dysfunctional monoaminergic neurons may be, at least in part, the cause of the behavioral anomalies.
- Published
- 2009
- Full Text
- View/download PDF
41. Different effects of 26-week dietary intake of rapeseed oil and soybean oil on plasma lipid levels, glucose-6-phosphate dehydrogenase activity and cyclooxygenase-2 expression in spontaneously hypertensive rats.
- Author
-
Ohara N, Kasama K, Naito Y, Nagata T, Saito Y, Kuwagata M, and Okuyama H
- Subjects
- Animals, Blood Glucose metabolism, Brain pathology, Cyclooxygenase 2 Inhibitors pharmacology, Erythrocytes enzymology, Fatty Acids, Monounsaturated, Hypertension blood, Hypertension enzymology, Hypertension genetics, Immunohistochemistry, Kidney pathology, Liver enzymology, Liver pathology, Male, Myocardium pathology, Plant Oils administration & dosage, Rapeseed Oil, Rats, Rats, Inbred SHR, Soybean Oil administration & dosage, Cyclooxygenase 2 metabolism, Glucosephosphate Dehydrogenase metabolism, Lipids blood, Plant Oils pharmacology, Soybean Oil pharmacology
- Abstract
We intended to determine whether or not dietary canola oil (CO) elevates plasma lipids and oxidative stress, since both of these are, possibly, related to the CO-induced life shortening through exacerbation of hypertension-associated vascular lesions found in stroke-prone spontaneously hypertensive rats (SHRSP). Spontaneously hypertensive rats (SHR) were used in this study to avoid a potential bias in the results due to the irregular death by stroke seen in SHRSP. SHR were fed for 26 weeks on a chow containing either, 10 wt/wt% of CO or soybean oil (SO), i.e., the control. Elevated plasma lipids and glucose-6-phosphate dehydrogenase (G6PD) activation in the liver and erythrocyte were found in SHR fed CO compared to that fed SO, while anti-oxidative enzymes other than G6PD were not activated. The CO diet brought about significant vascular lesions in the kidney, in which abundant cyclooxygenase-2 (COX-2) positive foci were immunochemically located in the juxtaglomerular apparatus. These results suggest that dietary CO induces a hyperlipidemic condition, in which G6PD may serve as an NADPH provider, and aggravates genetic diseases in SHR (also, probably, in SHRSP). The increased COX-2 expression indicates a role of renin-angiotensin-aldosterone system activation in the increased vascular lesions, whereas the effects of oxidative stress remain unclear.
- Published
- 2008
- Full Text
- View/download PDF
42. The evaluation of early embryonic neurogenesis after exposure to the genotoxic agent 5-bromo-2'-deoxyuridine in mice.
- Author
-
Kuwagata M, Ogawa T, Nagata T, and Shioda S
- Subjects
- Animals, Bromodeoxyuridine metabolism, Cell Death drug effects, Cell Proliferation drug effects, Embryo, Mammalian, Female, In Situ Nick-End Labeling, Mice, Mice, Inbred C57BL, Pregnancy, Stem Cells drug effects, Stem Cells physiology, Antimetabolites, Antineoplastic toxicity, Bromodeoxyuridine toxicity, Neurons drug effects, Prenatal Exposure Delayed Effects chemically induced, Prenatal Exposure Delayed Effects pathology, Prenatal Exposure Delayed Effects physiopathology
- Abstract
Developmental neurotoxicity (DNT) is an important issue in children's health. Neurogenesis occurs throughout the early fetal to the postnatal period. The proliferation of embryonic stem cells can be a target for toxicants, especially genotoxic compounds. 5-Bromo-2'-deoxyuridine (BrdU), a thymidine analogue, has been used as a marker for proliferating cells. However, we reported that prenatal BrdU exposure induced behavioral abnormalities such as hyperactivity in rat and mouse offspring. In this study, to further clarify the toxic effect of BrdU on the early neurogenesis and to examine the usefulness of the evaluation of this process in DNT, C57BL/6 mice were exposed to 100 mg/kg of BrdU once on gestational day (GD) 9 or 11, and serial sections from a wide variety of areas of the embryonic brains 24 h after the exposure were examined. BrdU exposure on GD11 induced cell death in some specific areas, such as the neocortex and striatum, but not in the substantia nigra, raphe and pons, even though BrdU was incorporated into those cells. BrdU decreased the number of cells positive for phosphorylated histone 3 (phospho-histone 3), a marker for proliferating cells at metaphase of mitosis, in the cortex, mammillary body and cerebellum, suggesting that BrdU affected the proliferation of neural stem cells. Exposure on GD9 did not induce cell death in the fetal brain. These results indicate that BrdU actually impaired the early neurogenesis, supporting the postnatal results, and demonstrated that embryonic neurogenesis has heterogeneous sensitivity to the genotoxic agents BrdU that differs according to the area and developmental stage. The evaluation of events in early neurogenesis such as the proliferation of neural stem cells shortly after chemical exposure will be one of the valuable endpoints for studying postnatal neurodevelopmental disorders.
- Published
- 2007
- Full Text
- View/download PDF
43. Dopamine transporter density and behavioral response to methylphenidate in a hyperlocomotor rat model.
- Author
-
Muneoka K, Kuwagata M, Iwata M, Shirayama Y, Ogawa T, and Takigawa M
- Subjects
- Animals, Attention Deficit Disorder with Hyperactivity chemically induced, Attention Deficit Disorder with Hyperactivity metabolism, Attention Deficit Disorder with Hyperactivity psychology, Bromodeoxyuridine, Disease Models, Animal, Female, Male, Pregnancy, Rats, Rats, Sprague-Dawley, Attention Deficit Disorder with Hyperactivity drug therapy, Behavior, Animal drug effects, Dopamine Plasma Membrane Transport Proteins metabolism, Methylphenidate pharmacology
- Abstract
Rats exposed prenatally to 5-bromo-2'-deoxyuridine (BrdU-rats) display hyperlocomotive activity, making them a possibly useful animal model for the study of attention deficit hyperactivity disorder (ADHD). Using this model, we investigated dopamine transporter (DAT) density and behavioral outcomes in BrdU-rats, some of which were also administered methylphenidate, a psychostimulant that is widely used for the treatment of ADHD. Pregnant rats were exposed to BrdU from gestational day 9 through 15. In male offspring, DAT densities in different regions of the striatum were quantified at three weeks of age. At seven weeks of age, locomotor, rearing and grooming behaviors were evaluated in an open-field setting, with or without methylphenidate treatment (1 mg/kg or 4 mg/kg). The results revealed no significant changes in striatal DAT densities in BrdU-rats compared with controls. Extreme hyperlocomotion of BrdU-rats was detected in the open-field environment, an effect that was exacerbated following treatment with the lower and higher dose of methylphenidate. Such increase in locomotor activity was observed only with the higher dose in control animals. In summary, degeneration of dopaminergic neurons in the terminal field was not detected in juvenile BrdU-rats, although adult animals displayed hyperactive behavior in a mildly stressful environment as well as hypersensitivity to a psychostimulant that facilitates dopaminergic neurotransmission.
- Published
- 2006
- Full Text
- View/download PDF
44. Inducible nitric oxide synthase inhibitors abolished histological protection by late ischemic preconditioning in rat retina.
- Author
-
Sakamoto K, Yonoki Y, Kubota Y, Kuwagata M, Saito M, Nakahara T, and Ishii K
- Subjects
- Animals, Enzyme Inhibitors pharmacology, Indazoles pharmacology, Ischemia pathology, Lysine pharmacology, Male, NG-Nitroarginine Methyl Ester pharmacology, Nitric Oxide Synthase antagonists & inhibitors, Nitric Oxide Synthase Type I antagonists & inhibitors, Nitroarginine pharmacology, Rats, Rats, Sprague-Dawley, Retina drug effects, Retinal Vessels, Guanidines pharmacology, Ischemia prevention & control, Ischemic Preconditioning methods, Lysine analogs & derivatives, Nitric Oxide Synthase Type II antagonists & inhibitors, Retina pathology
- Abstract
Brief ischemia was reported to protect retinal cells against injury induced by subsequent ischemia-reperfusion with de novo protein synthesis, and this phenomenon is known as late ischemic preconditioning. The aims of the present study were to determine whether nitric oxide synthase (NOS) was involved in the mechanism of late ischemic preconditioning in rat retina using pharmacological tools. Under anesthesia with pentobarbital sodium, male Sprague-Dawley rats were subjected to 60 min of retinal ischemia by raising intraocular pressure to 130 mm Hg. Ischemic preconditioning was achieved by applying 5 min of ischemia 24 hrs before 60 min of ischemia. Retinal sections sliced into 5 microm thick were examined 7 days after ischemia. Additional groups of rats received NG-nitro-L-arginine and NG-monomethyl-L-arginin, non-selective NO synthase inhibitors, 7-nitroindazole, a neuronal NOS inhibitor, and aminoguanidine and L-N6-(1-iminoethyl) lysine, inducible NO synthase (iNOS) inhibitors before preconditioning, and were subjected to 60 min of ischemia. In the non-preconditioned group, cell loss in the ganglion cell layer and thinning of the inner plexiform and inner nuclear layer were observed 7 days after 60 min of ischemia. Ischemic preconditioning for 5 min completely protected against the histological damage induced by 60 min of ischemia applied 24 hrs thereafter. Treatment of rats with aminoguanidine and L-N6-(1-iminoethyl) lysine, but not NG-nitro-L-arginine, NG-monomethyl-L-arginine or 7-nitroindazole, wiped off the protective effect of ischemic preconditioning. The inhibitory effect of aminoguanidine was abolished by L-arginine, but not D-arginine. The results in the present study suggest that NO synthesized by iNOS is involved in the histological protection by late ischemic preconditioning in rat retina.
- Published
- 2006
- Full Text
- View/download PDF
45. Differential teratogenic effect of alcohol on embryonic development between C57BL/6 and DBA/2 mice: a new view.
- Author
-
Ogawa T, Kuwagata M, Ruiz J, and Zhou FC
- Subjects
- Abnormalities, Drug-Induced pathology, Animals, Female, Fetal Viability drug effects, Fetus pathology, Mice, Mice, Inbred C57BL, Mice, Inbred DBA, Organ Culture Techniques, Pregnancy, Species Specificity, Central Nervous System Depressants toxicity, Embryonic Development drug effects, Ethanol toxicity, Teratogens
- Abstract
Background: Alcohol exposure during the fetal stage generates variable severity in different organs, as seen in fetal alcohol syndrome and fetal alcohol effect. Whether genetic factors or conditions of alcohol exposure influence the susceptibility to alcohol-related developmental impairment remains a question., Methods: To investigate the contribution of genotype to the susceptibility to alcohol-induced toxicity during development beyond confounding maternal factors and variables of alcohol exposures, the authors tested the effect of alcohol exposure under definitive concentration using a whole embryonic culture of two inbred strains previously known to be vulnerable (C57BL/6 [C6]) or resistant (DBA/2 [D2]) to alcohol. On gestational day 8, embryos from each group bearing three to six somites were collected and then cultured for 44 hr in a medium added with 400 mg/dl of ethanol. The viability and morphological malformations, as well as developmental staging of the embryos, were all scored at the end of the culture., Results: The authors found, in contrast to previous reports, that alcohol treatment retarded embryonic growth and induced abnormalities, including the neural tube opening and the hypoplasia of the optic vesicle in both strains. However, alcohol specifically compromised the heart and caudal neural tube in C6, whereas it specifically decreased the number of somites and the development of branchial bars among others in D2., Conclusions: These results demonstrated that both strains of embryos are vulnerable to the same amount and pattern of alcohol exposures at the same developmental stage, but each with unique vulnerability in specific organs, with alcohol having greater teratogenic effects in D2 than in C6. These differential vulnerabilities are results of greater genetic influence, rather than the maternal influence or conditions of alcohol.
- Published
- 2005
- Full Text
- View/download PDF
46. Neuropathological examination of fetal rat brain in the 5-bromo-2'-deoxyuridine-induced neurodevelopmental disorder model.
- Author
-
Ogawa T, Kuwagata M, Muneoka KT, and Shioda S
- Subjects
- Abnormalities, Drug-Induced embryology, Abnormalities, Drug-Induced metabolism, Abnormalities, Drug-Induced pathology, Animals, Brain metabolism, Brain pathology, Cell Death drug effects, Disease Models, Animal, Female, Fetus drug effects, Fetus pathology, Immunohistochemistry, Male, Microtubule-Associated Proteins metabolism, Pregnancy, Rats, Rats, Sprague-Dawley, Teratogens toxicity, Brain abnormalities, Brain drug effects, Bromodeoxyuridine toxicity
- Abstract
The majority of prior developmental neurotoxicity studies focused on postnatal subjects rather than on the fetus. In the present paper, we demonstrate the use of histological examination of fetal rat (embryonic day 16.5) brain serial sections, employing Nissl staining and microtubule-associated protein 2 (MAP2) immunohistochemistry, in evaluating a chemical-induced neurodevelopmental disorder. Since prenatal treatment with 5-bromo-2'-deoxyuridine (BrdU) is known to induce behavioral abnormalities such as locomotor hyperactivity in offspring, pregnant rats were administered 50 mg/kg on gestation days 9.5 through 15.5. The fetal brains at embryonic day 16.5 were collected and processed for neuropathological study. Cell death, including DNA strand breaks, was observed in specific areas of the fetal brain such as the neuroepithelium, intermediate zone and/or differentiating zones (e.g. neocortex and striatum) in exposed fetuses. In addition, the neocortex had an abnormal appearance cortical plate, which was also detected by MAP2 immunohistochemistry. The abnormal cortical plate was observed consistently, while the grade of cell death was generally very mild and variable. No significant alteration was detected in the brainstem. The present study reveals that histological observation of the fetal brain includes sensitive endpoints in developmental neurotoxicity, and that BrdU, at a dose generally administered to label proliferating cells, affects the development of the fetal neocortex.
- Published
- 2005
- Full Text
- View/download PDF
47. Locomotor hyperactivity following prenatal exposure to 5-bromo-2'-deoxyuridine: neurochemical and behavioral evidence of dopaminergic and serotonergic alterations.
- Author
-
Kuwagata M, Muneoka KT, Ogawa T, Takigawa M, and Nagao T
- Subjects
- Animals, Disease Models, Animal, Dopamine Antagonists pharmacology, Female, Male, Pregnancy, Rats, Rats, Sprague-Dawley, Antimetabolites, Antineoplastic toxicity, Attention Deficit Disorder with Hyperactivity physiopathology, Bromodeoxyuridine toxicity, Motor Activity drug effects, Prenatal Exposure Delayed Effects, Receptors, Dopamine D2 drug effects, Receptors, Dopamine D2 physiology, Receptors, Serotonin drug effects, Receptors, Serotonin physiology
- Abstract
Prenatal exposure to 5-bromo-2'-deoxyuridine (BrdU) has been reported to induce abnormal behaviors in offspring, including marked hyperactivity. In this study, the contribution of the serotonin (5-HT) and dopamine (DA) systems to BrdU-induced developmental neurotoxicity was investigated. Sprague-Dawley rats were treated with BrdU on gestational days 9 through 15 (50mg/kg, i.p.) and male offspring (BrdU-rats) were examined. The BrdU-rats exhibited a 3.5-fold increase in locomotor activity. The dopamine D2 receptor antagonist sulpiride increased locomotor activity in the BrdU-rats, but decreased it in control rats. The BrdU-rats responded to the 5-HT1A receptor antagonist NAN190 much more than the controls. The measurement of monoamines revealed significant decreases in DA, dihydroxyphenylacetic acid, and homovanilic acid, and significant increases in 5-HT and 5-hydroxy-3-indolacetic acid, with a decrease in the 5-HT turnover ratio in the striatum of BrdU-rats. Thus, prenatal exposure to BrdU induced alterations in both the DA and 5-HT systems.
- Published
- 2004
- Full Text
- View/download PDF
48. Histological protection against ischemia-reperfusion injury by early ischemic preconditioning in rat retina.
- Author
-
Sakamoto K, Yonoki Y, Kuwagata M, Saito M, Nakahara T, and Ishii K
- Subjects
- Adrenergic alpha-Antagonists pharmacology, Animals, Enzyme Inhibitors pharmacology, Intraocular Pressure physiology, Male, Potassium Channel Blockers pharmacology, Purinergic P1 Receptor Antagonists, Rats, Rats, Sprague-Dawley, Reperfusion Injury pathology, Retina drug effects, Theophylline pharmacology, Time Factors, Xanthines pharmacology, Ischemia pathology, Ischemic Preconditioning, Reperfusion Injury prevention & control, Retina pathology, Retinal Vessels, Theophylline analogs & derivatives
- Abstract
Brief ischemia was reported to protect various cells against injury induced by subsequent ischemia-reperfusion, and this phenomenon is known as ischemic preconditioning. The aims of the present study were to clarify whether early ischemic preconditioning could be observed in the rat retina by histological examination. Male Sprague-Dawley rats were subjected to 60 min of retinal ischemia by raising intraocular pressure to 130 mm Hg. Ischemic preconditioning was achieved by applying 5 min of ischemia 5-60 min before 60 min of ischemia. Additional groups of rats received 10 mg/kg 8-phenyltheophiline and 4.5 mg/kg 8-cyclopentyl-1,3-dipropylxanthine (DPCPX), adenosine A1 receptor antagonists, 5 mg/kg 5-hydroxydecanoate and 1 mg/kg glibenclamide, ATP-sensitive K+ channel blockers, or 2.5 mg/kg chelerythrine and 0.1 mg/kg bisindolylmaleimide I, protein kinase C inhibitors, 15 or 30 min before preconditioning. In the non-preconditioned group, cell loss in the ganglion cell layer and thinning of the inner plexiform and inner nuclear layer were observed 7 days after 60 min of ischemia. Five minutes of preconditioning ischemia 20-40 min before 60 min of sustained ischemia completely prevented the retinal tissue damage induced by the sustained ischemia. Treatment with 8-phenyltheophylline, DPCPX, 5-hydroxydecanoate, glibenclamide, chelerythrine and bisindolylmaleimide I almost completely reduced the protective effect of early ischemic preconditioning. The results in the present study indicated that early ischemic preconditioning was demonstrated in the rat retina. Stimulation of adenosine receptors, opening of ATP-sensitive K+ channels and activation of protein kinase C might be involved in the underlying protective mechanisms.
- Published
- 2004
- Full Text
- View/download PDF
49. Intrauterine position and postnatal growth in Sprague-Dawley rats and ICR mice.
- Author
-
Nagao T, Wada K, Kuwagata M, Nakagomi M, Watanabe C, Yoshimura S, Saito Y, Usumi K, and Kanno J
- Subjects
- Anal Canal anatomy & histology, Animals, Estradiol toxicity, Estrus, Female, Fetal Movement, Fetal Weight, Genitalia anatomy & histology, Male, Mice, Mice, Inbred ICR, Motor Activity, Organ Size, Pregnancy, Prenatal Exposure Delayed Effects, Rats, Rats, Sprague-Dawley, Sexual Maturation, Fetus physiology, Growth
- Abstract
In rodents, steroid hormones are thought to be transported between adjacent fetuses, and male or female fetuses that develop in utero between female fetuses may have higher serum levels of estradiol, and lower serum levels of testosterone, relative to siblings of the same sex that develop between two male fetuses. The consequence in the variation of postnatal growth, development, and function in the intrauterine position, using various parameters such as anogenital distance, preputial separation and vaginal opening, estrous cycle, locomotor activity, and growth of reproductive organs, were examined in Sprague-Dawley rats. ICR mice were treated with 17beta-estradiol before copulation and during pregnancy to address the interaction with endogenous estradiol during pregnancy. In rats, no evidence of effects of prior intrauterine position was observed for any of the parameters examined. Mouse fetal exposure via the mother to low-dose 17beta-estradiol revealed no changes in the rate of postnatal growth in males and females that developed in any intrauterine position in utero. The results of this study suggested that the intrauterine position of the embryos/fetuses did not affect the postnatal growth of the reproductive organs, sexual maturation, or behavior in rats and mice.
- Published
- 2004
- Full Text
- View/download PDF
50. An improved technique for repeated gavage administration to rat neonates.
- Author
-
Watanabe C, Kuwagata M, Yoshimura S, Azegami J, Kojima K, Ono H, and Nagao T
- Subjects
- Administration, Oral, Animals, Animals, Newborn, Body Weight, Female, Longevity, Male, Organ Size, Pregnancy, Rats, Sprague-Dawley, Rats growth & development, Water administration & dosage
- Abstract
The technique for gavage administration to rat nurslings was improved to allow determination of the direct effects of chemical substances in the nurslings. Rat neonates were treated with distilled water from postnatal day 1 through 20 using this technique. The viability of neonates during the administration period was comparable to that of untreated neonates. No adverse effects of this technique on the development of neonates were found, and no histological alterations of the esophagus or pharynx. Therefore, we conclude that use of our improved gavage administration method will contribute to ensuring successful neonatal development and thus allowing accurate assessment of the toxicological effects of test compounds on rat nurslings.
- Published
- 2003
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.